التفاصيل البيبلوغرافية
| العنوان: |
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAFV600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study. |
| المؤلفون: |
Raje, Noopur1, Yee, Andrew J.1, Puzanov, Igor2, Chau, Ian3, Kaiser, Martin3, Hyman, David M.3, Landau, Heather3, Baselga, Jose3, Ribrag, Vincent3, Michot, Jean-Marie3, Hollebecque, Antoine3, Blay, Jean-Yves3, Tabernero, Josep3, Elez, Elena3, Wolf, Jürgen3, Veronese, Luisa3, Makrutzki, Martina3, Pitcher, Bethany3 |
| المصدر: |
JCO Precision Oncology. 2018, Vol. 2, p1-9. 9p. |
| مصطلحات موضوعية: |
*MULTIPLE myeloma treatment, *CANCER relapse, *BRAF genes, *DISEASE progression, *GENETIC mutation, *MULTIPLE myeloma, *COHORT analysis, *PROGNOSIS |
| مستخلص: |
The article presents a case study of patients undergoing treatment with Vemurafenib (VE) following a relapsed refractory multiple myeloma (MM) harboring BRAFV600 mutations. The article presents a cohort of the histology-independent VE-Basket study as the authors report the efficacy and safety findings in a cohort of patients with MM. Topics include prognosis of MM, immunofixation analyses, and disease progression. |
| قاعدة البيانات: |
Academic Search Index |
